H19, one of the first identified lncRNAs in the early 1990s, was found to be involved in a tumor development promotion, being activated by oncogenic pathways such as PI3K/AKT [237], acting by sponging notable tumor suppressive miRNAs, for example let-7 [238]. This evidence concerns the gene H19 and neoplasm.